POL-0004 : drug good manufacturing practices (GMP) and drug establishment licence (DEL) enforcement policy.: H139-40/2022E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.909298&sl=0

Publication information
Department/Agency Canada. Health Canada, issuing body.
Title POL-0004 : drug good manufacturing practices (GMP) and drug establishment licence (DEL) enforcement policy.
Publication type Monograph
Language [English]
Other language editions [French]
Format Electronic
Electronic document
Note(s) Issued also in French under title: POL-0004 : Politique d'application de la loi pour les bonnes pratiques de fabrication (BPF) des médicaments et les licences d’établissement de produits pharmaceutiques (LEPP).
Issued also in HTML format.
Replaces: Good Manufacturing Practices (GMP) and Establishment Licensing Enforcement Directive, v3 (August 31, 2018).
"April 1, 2022."
Publishing information [Ottawa] : Health Canada = Santé Canada, 2022.
©2022
Description 1 online resource (17 pages)
ISBN 9780660426587
Catalogue number
  • H139-40/2022E-PDF
Departmental catalogue number 210747
Subject terms Drug factories -- Canada.
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.
Report a problem or mistake on this page
Date modified: